Search results for "Album"

showing 10 items of 724 documents

Microalbuminuria and oxidative stress in essential hypertension

2004

. Objective.  To assess the relationship between microalbuminuria and oxidative stress in mononuclear peripherals cells in essential hypertension. Methods.  A total of 123 hypertensive patients in absence of antihypertensive treatment were included. A 24-h ambulatory blood pressure (BP) monitoring was performed using a Spacelabs 90207 monitor, and microalbuminuria was measured in 24-h urine collections. Oxidized/reduced glutathione ratio and the content of malondialdehide and damaged base 8-oxo-2′-deoxyguanosine in genomic and mitochondrial DNA were measured in peripheral mononuclear cells. Results.  In the 29 (24%) microalbuminuric subjects, the amount of reduced glutathione was significan…

AdultMalemedicine.medical_specialtyAmbulatory blood pressuremedicine.disease_causeEssential hypertensionExcretionchemistry.chemical_compoundInternal medicineInternal MedicinemedicineAlbuminuriaHumansProteinuriabusiness.industryAlbuminGlutathioneBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseOxidative StressEndocrinologychemistryHypertensionRegression AnalysisFemaleMicroalbuminuriamedicine.symptombusinessOxidative stressJournal of Internal Medicine
researchProduct

Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.

2013

The objective of the present study was to assess the regression of left ventricular hypertrophy (LVH) during antihypertensive treatment, and its relationship with the changes in microalbuminuria.One hundred and sixty-eight previously untreated patients with echocardiographic LVH, 46 (27%) with microalbuminuria, were followed during a median period of 13 months (range 6-23 months) and treated with lifestyle changes and antihypertensive drugs. Twenty-four-hour ambulatory blood pressure monitoring, echocardiography and urinary albumin excretion were assessed at the beginning and at the end of the study period.Left ventricular mass index (LVMI) was reduced from 137 [interquartile interval (IQI)…

AdultMalemedicine.medical_specialtyAngiotensin receptorAmbulatory blood pressurePhysiologyHeart VentriclesBlood PressureLeft ventricular hypertrophyExcretionInterquartile rangeRisk FactorsInternal medicineAlbuminsInternal MedicineMedicineAlbuminuriaHumanscardiovascular diseasesAntihypertensive Agentsbusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseRegressionBlood pressureTreatment OutcomeEchocardiographyHypertensionCardiologyMicroalbuminuriaFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateJournal of hypertension
researchProduct

Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic dono…

1998

Plasma of patients with Tangier disease (TD) is devoid of alpha-LpA-I (apolipoprotein A-I-containing lipoprotein), which in normolipidemic plasma constitutes the majority of high density lipoprotein (HDL). The residual amounts of apolipoprotein A-I (apo A-I) in TD plasma have electrophoretic prebeta1-LpA-I mobility. We have previously demonstrated that TD plasma does not convert prebeta1-LpA-I into alpha-LpA-I. In this study we found that plasmas of normolipidemic controls, apo A-I-deficient patients and patients with fish-eye disease, but not plasmas of six TD patients, convert biotinylated lipid-free apo A-I into alpha-LpA-I. Supplementation of plasma with free oleic acid or fatty acid fr…

AdultMalemedicine.medical_specialtyApolipoprotein BLipoproteinsBlood Donorschemistry.chemical_compoundTangier diseaseHigh-density lipoproteinReference ValuesPhospholipid transfer proteinInternal medicinemedicineHumansPhospholipidsTangier DiseaseAgedApolipoprotein A-IbiologyChemistryCholesterolVesicleAlbuminMiddle Agedmedicine.diseaseEndocrinologybiology.proteinFemalelipids (amino acids peptides and proteins)Lipoproteins HDLCardiology and Cardiovascular MedicineLipoproteinAtherosclerosis
researchProduct

Serum levels of substance P are decreased in patients with type 1 diabetes.

2000

Morphological and immunohistochemical studies in diabetic subjects have shown a depletion of the neuropeptide substance P (SP) in the central and peripheral nervous system. This is the first study investigating serum levels of substance P in type 1 diabetes patients (n=50) and controls (n=75) by means of an enzyme immunoassay. The serum level of SP was significantly decreased in the diabetic group compared to the control group (10.12+/-0.29 vs. 12.25+/-0.38 pg/ml; p<0.0001). In diabetic patients, there was no correlation of substance P levels with age, serum creatinine, albuminuria, total cholesterol, HDL- or LDL-cholesterol, triglycerides, HbA1c, type or duration of diabetes and gender. Fu…

AdultMalemedicine.medical_specialtyDiabetic neuropathyAdolescentEndocrinology Diabetes and MetabolismSubstance PSubstance PImmunoenzyme Techniqueschemistry.chemical_compoundEndocrinologyReference ValuesInternal medicineDiabetes mellitusBlood plasmaInternal MedicinemedicineHumansAgedType 1 diabetesCreatininebusiness.industryGeneral MedicineMiddle Agedmedicine.diseasePeripheral neuropathyEndocrinologyCholesterolDiabetes Mellitus Type 1chemistryAlbuminuriaFemalemedicine.symptombusinessExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Cardiovascular autonomic neuropathy in type 1 diabetic patients with and without peripheral neuropathy.

1998

One hundred Type 1 diabetic patients (54 men, 46 women) mean age 28.9 +/- 8.4 years, were selected from among individuals referred to our hospital, with no previous diagnosis of diabetic chronic complications including diabetic neuropathy. After clinical and physical examinations, subjects were divided into two groups: with (n = 37) and without (n = 63) peripheral neuropathy. The percentage of subjects with cardiovascular autonomic neuropathy (AN), diagnosed by positive results to at least two of the five cardiovascular tests (Valsalva ratio, EI ratio, 30/15 ratio, blood-pressure response to standing up and handgrip test), was 40%: 72.9% in the group with peripheral neuropathy and 20.6% in …

AdultMalemedicine.medical_specialtyDiabetic neuropathyAdolescentValsalva ManeuverEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPostureBlood PressureAutonomic Nervous SystemGastroenterologyEndocrinologyDiabetic NeuropathiesDiabetes mellitusInternal medicineInternal MedicinemedicineValsalva maneuverAlbuminuriaHumansPeripheral NervesType 1 diabetesProteinuriaDiabetic RetinopathyHand Strengthbusiness.industryPeripheral Nervous System DiseasesGeneral MedicineMiddle Agedmedicine.diseaseSurgeryPeripheral neuropathyDiabetes Mellitus Type 1Autonomic Nervous System DiseasesMicroalbuminuriaFemalemedicine.symptombusinessRetinopathyDiabetes research and clinical practice
researchProduct

OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes.

2009

Optical coherence tomography (OCT) has been proven useful in measuring retinal thickness (RT) in patients with diabetes, although with discordant results in different studies. We examined RT in patients with type 1 diabetes (T1D) with or without minimal diabetic retinopathy (MDR) to test whether OCT is able to identify early retinal changes and potential correlations with metabolic parameters. RT of 102 patients with T1D (53 females, 49 males, aged 27.03 +/- 7.4 years) and of 42 healthy controls was examined, with analysis of nine different sectors (fovea, four pericentral and four peripheral sectors). According to the results of basal fundus photography, patients were divided into two grou…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismGastroenterologyRetinaSettore MED/13 - EndocrinologiaYoung AdultEndocrinologyOptical coherence tomography (OCT) type 1 diabetes (T1D) minimal diabetic retinopathy (MDR)retinal thickness (RT)Predictive Value of TestsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsInsulinMacular edemaType 1 diabetesDiabetic Retinopathymedicine.diagnostic_testbusiness.industrySettore MED/30 - Malattie Apparato VisivoFundus photographyGeneral MedicineDiabetic retinopathymedicine.diseaseRadiographyEndocrinologyDiabetes Mellitus Type 1Predictive value of testsMicroalbuminuriaFemalebusinessMedical FutilityTomography Optical CoherenceRetinopathy
researchProduct

Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease

2018

OBJECTIVE The effect of pentoxifylline on Klotho levels in patients with type 2 diabetes mellitus with chronic kidney disease (CKD) was assessed in a post hoc analysis of the Pentoxifylline for Renoprotection in Diabetic Nephropathy (PREDIAN) trial. RESEARCH DESIGN AND METHODS Circulating and urinary tumor necrosis factor-α (TNF-α) and Klotho were measured before and after 1 year of pentoxifylline. The effect on Klotho expression was assessed in cultured renal tubular cells. RESULTS Pentoxifylline administration resulted in decreased serum and urinary TNF-α, whereas serum and urinary Klotho increased significantly. Changes in urinary Klotho, urinary TNF-α, and phosphorus were associated wi…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismUrinary system030232 urology & nephrologyRenal function030204 cardiovascular system & hematologyKidneyurologic and male genital diseasesPentoxifyllineDiabetic nephropathyMice03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineAlbuminuriaAnimalsHumansMedicineDiabetic NephropathiesPentoxifyllineRenal Insufficiency ChronicKlotho ProteinsKlothoCells CulturedAgedGlucuronidaseAdvanced and Specialized NursingTumor Necrosis Factor-alphabusiness.industryKidney metabolismMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsKidney TubulesEndocrinologyDiabetes Mellitus Type 2AlbuminuriaFemalemedicine.symptombusinessFollow-Up StudiesGlomerular Filtration RateKidney diseasemedicine.drugDiabetes Care
researchProduct

Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes

2013

Urinary adiponectin (u-adiponectin) excretion has been suggested to reflect early glomerular damage. Inspired by this, we studied the levels of u-adiponectin in type 1 diabetic patients with different levels of urinary albumin excretion (UAE).U-adiponectin was analysed by ELISA in type 1 diabetic patients: Fifty-eight with normoalbuminuria (30mg albumin/24h), 43 with persistent microalbuminuria (30-300mg/24h) and 44 with persistent macroalbuminuria (300mg/24h). For comparison, a control group of 55 healthy individuals was included.U-adiponectin increased with increasing levels of UAE (p0.01). U-adiponectin median (interquartile range): Normoalbuminuria 0.38 (0.14-1.31), microalbuminuria 1.1…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismUrinary systemExcretionEndocrinologyDiabetes mellitusInternal medicineInternal MedicineMedicineAlbuminuriaHumansIn patientAgedType 1 diabetesAdiponectinbusiness.industrynutritional and metabolic diseasesMiddle Agedmedicine.diseaseUp-RegulationEndocrinologyCross-Sectional StudiesDiabetes Mellitus Type 1Healthy individualsCase-Control StudiesAlbuminuriaFemaleAdiponectinmedicine.symptombusinesshormones hormone substitutes and hormone antagonistsGlomerular Filtration Rate
researchProduct

Morbidity in 565 Type 2 Diabetic Patients According to Stage of Nephropathy

1998

Between 1988 and 1992, 565 type 2 diabetic patients were examined for nephropathy and diabetes-associated diseases during hospital treatment. Stages of nephropathy were defined as no clinical sign of nephropathy (N = 280), microalbuminuria (N = 38), overt proteinuria (N = 105), impaired renal function (N = 55), and chronic dialysis therapy (N = 87). In dialyzed patients, HbA1c averaged 6.8%, and, in the other groups, HbA1c was between 7.6% and 8.3% (normal range, 3.8%-6.1%). Cataract was not associated with the severity of nephropathy. Stroke was most common in the stage of renal insufficiency (34%). The following complications, as found in medical history or as current event, showed a sign…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMyocardial InfarctionBlood PressureGastroenterologyNephropathyCohort StudiesDiabetic nephropathyEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansCarotid StenosisDiabetic NephropathiesRenal replacement therapyAgedDiabetic RetinopathyProteinuriabusiness.industryMiddle Agedmedicine.diseaseSurgeryRenal Replacement TherapyCerebrovascular DisordersProteinuriaDiabetes Mellitus Type 2HypertensionAlbuminuriaFemaleHypertrophy Left VentricularMicroalbuminuriaMorbiditymedicine.symptombusinessKidney diseaseJournal of Diabetes and its Complications
researchProduct

White-coat hypertension and cardiovascular risk

1995

OBJECTIVE: To compare cardiovascular risk in white-coat hypertensives, normotensives and established hypertensives. METHODS: We studied 61 hypertensive individuals, 27 of whom were white-coat hypertensives, and 35 normotensives. All subjects underwent 24 h noninvasive blood pressure monitoring and Doppler echocardiographic examination of the heart; urine was tested for microalbuminuria and the fundi of the eyes examined for retinopathy. RESULTS: The 24 h as well as the day- and night-time mean systolic blood pressure (SBP) was slightly but significantly higher in white-coat hypertensives than in normotensives; no significant difference was observed in diastolic blood pressure (DBP) between …

AdultMalemedicine.medical_specialtyEpidemiologyWhite coat hypertensionCoronary DiseaseUrineLower riskVentricular Function LeftRisk FactorsInternal medicineMedicineAlbuminuriaHumansPhysician-Patient RelationsEjection fractionbusiness.industryMiddle Agedmedicine.diseaseBlood pressureCross-Sectional StudiesEchocardiographyHypertensionCardiologyAlbuminuriaMicroalbuminuriaFemalemedicine.symptombusinessCardiology and Cardiovascular MedicineStress PsychologicalRetinopathy
researchProduct